コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ildren younger than 8 weeks who were not yet immunised.
3 xtent specific groups, such as refugees, are immunised according to host country schedules, and the i
5 ntrolled trial of 726 previously healthy non-immunised adults with febrile influenza-like illness of
6 candidates were safe and immunogenic in IPV-immunised adults, and our data support the further devel
7 ase (AD) cases and 16 AD cases from patients immunised against AB42 (iAD) using 2D and 3D approaches.
8 but the challenge to ensure all infants are immunised against the most common infections of childhoo
9 d Hib cases with those administered to fully immunised age-matched controls using conditional logisti
10 t cost-effective strategy was to selectively immunise all children born before the start of the RSV s
12 oportion of children aged 12-23 months fully immunised, and proportion of children younger than 5 yea
14 confirmed influenza in infants born to women immunised any time prepartum (intention-to-treat populat
15 nd vaccine efficacy in infants born to women immunised at least 14 days prepartum (per-protocol popul
19 comes including a higher proportion of fully immunised children (risk ratio [RR] 1.3 [95% CI 1.0-1.5]
22 tors (primary outcomes): proportion of fully immunised children, use of oral rehydration solution, an
26 ity (>50% of adults aged 18-64 years must be immunised [either by vaccination or infection]; >50% of
27 nation or infection]; >50% of adults must be immunised [either by vaccination or infection]; or no in
30 e basis of the number of additional children immunised from surveys at a rate of US$20 each, GAVI ISS
32 ith repertoires of variable domains from non-immunised human donors followed by selection on biotinyl
33 ly, received money if their child was timely immunised (immunisation within 2 weeks of the due date).
34 sed, the estimated cost per additional child immunised in countries with baseline coverage of 65% or
36 show greater T cell responses when mice are immunised in the middle of their rest versus their activ
38 ipants compared with 73% (68-78) in multiply immunised individuals (ie, those with at least two vacci
40 beta load and degree of plaque removal among immunised participants, the degree of plaque removal var
45 engraftment did not occur in one of the five immunised Tasmanian devils, and regression followed ther
46 istry of Health (MoH) launched a campaign to immunise the 6.5 million residents of Israel aged 16 yea
47 (pooled adjusted OR 0.54 [0.42-0.71]) or to immunise their children (0.57 [0.44-0.74]) compared with
50 derived, MHC-typed cynomolgus macaques were immunised with 10(5) TCID(50) of MV1-F4, four of which w
52 and haemophilus antibody concentrations were immunised with 23 polyvalent pneumococcal and tetanus-ha
55 ypes at age 2-4 years in children previously immunised with a 3+0 schedule compared with a 2+1 schedu
56 oached mAb production in a different way and immunised with a complex mixture of polysaccharides.
57 h adults aged 50 years and older, previously immunised with a single dose of ChAd or BNT in the commu
61 V2 challenge did not differ between children immunised with bOPV and one or two doses of IPV and thos
63 ion to 9.2 million) additional children were immunised with DTP3 based on surveys compared with offic
65 rom pooled serum samples from healthy adults immunised with licensed rabies vaccine, were generated.
66 In this study, hyperimmune plasma from sheep immunised with whole spike SARS-CoV-2 recombinant protei
67 arations obtained from the plasma of animals immunised with whole venom(s) and contain antibodies aga